Uptake, Localization and Release of Taurine in the Rat Basal Ganglia

  • L. Della Corte
  • D. J. Clarke
  • J. P. Bolam
  • A. D. Smith
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 217)

Abstract

Although taurine (2-aminoethanesulfonic acid) has long been known to be present in high concentrations in the mammalian CNS, the suggestion that it may act as an inhibitory neurotransmitter or neuromodulator in the brain is relatively recent (1,6,23). Among other areas in the brain, especially high concentrations of taurine and its synthetic enzyme, cysteine sulfinic acid decarboxylase have been found in the neostriatum (ST) and substantia nigra (SN) (7,8,17,30,31). In spite of this, very little is known about the function of taurine in the basal ganglia. The inhibitory action exerted on nigral neurons by iontophoretic application of taurine (5) and the contralateral circling behavior induced by taurine injections into the SN (12, 13,20) suggest some role for this amino acid in nigral functions.

Keywords

Substantia Nigra Kainic Acid Selective Accumulation Fractional Release Taurine Release 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barbeau, A., Inoue, N., Tsukada, A., and Butterworth, R.F., 1975, The neuropharmacology of taurine, Life Sci., 17:669–678.PubMedCrossRefGoogle Scholar
  2. 2.
    Blackett, N.M., and Parry, D.M., 1977, A simplified method of “hypothetical grain” analysis of electron microscope autoradiographs, J. Histochem. Cytochem., 25:206–214.PubMedCrossRefGoogle Scholar
  3. 3.
    Clarke, D.J., Smith, A.D., and Bolam, J.P., 1983, Uptake of [3H]taurine into medium-size neurons and into identified strlatonigral neurons in the rat neostriatum, Brain Res., 289:342–348.PubMedCrossRefGoogle Scholar
  4. 4.
    Collins, G.G.S., 1974, The rates of synthesis, uptake and disappearance of [14C]-taurine in eight areas of the rat central nervous system, Brain Res., 76:447–459.PubMedCrossRefGoogle Scholar
  5. 5.
    Davies, J., and Dray A., 1976, Changes in amino acid sensitivity during polypeptide ‘desensitisation’, Nature, 262:606–607.PubMedCrossRefGoogle Scholar
  6. 6.
    Davison, A.N., and Kaczmarek, L.K., 1971, Taurine — a possible neurotransmitter?, Nature, 234:107–109.PubMedCrossRefGoogle Scholar
  7. 7.
    Dray, A., and Straughan, D.W., 1976, Synaptic mechanisms in the substantia nigra, J. Pharm. Pharmac, 28:400–405.CrossRefGoogle Scholar
  8. 8.
    Emson, P.C., 1978, “Biochemical and metabolic changes in epilepsy” in: “Taurine in Neurological Disorders”, R. J. Huxtable, and A. Barbeau eds., Raven Press, New York, pp. 319–338.Google Scholar
  9. 9.
    Freund, T.F., and Somogyi, P., 1983, The section-Golgi impregnation procedure. 1. Description of the method and its combination with histochemistry after intracellular iontophoresis or retrograde transport of horseradish peroxidase, Neuroscience, 9:463–474.PubMedCrossRefGoogle Scholar
  10. 10.
    Girault, J.A., Barbeito, L. Spampinato, U., Gozlan, H., Glowinski, J., and Besson, M-J., 1986, In vivo release of endogenous amino acids from the rat striatum: further evidence for a role of glutamate and asparate in corticostriatal neurotransmission, J. Neurochem., 47:98–106.PubMedCrossRefGoogle Scholar
  11. 11.
    Goldstein, A., Biostatics, an Introductory Text, Macmillan, New York (1964).Google Scholar
  12. 12.
    Kaakkola, S., and Kaariainen, I., 1980, Contralateral circling behavior induced by intranigral injection of taurine in rats, Acta Pharmacol. Toxicol., 46:293–298.CrossRefGoogle Scholar
  13. 13.
    Kamata, K. Kameyana, T., Okuyama, S., Hashimoto, S., and Aihara, H., 1985, Contralateral circling behavior Induced by intranigral microinjections of taurine and GABA in rats, Brain Res., 343:275–282.PubMedCrossRefGoogle Scholar
  14. 14.
    Katz, R.I., Chase, T.N., and Kopin, I.J., 1969, Effect of ions on stimulus induced release of amino acids from mammalian brain slices, J. Neurochem., 16:961–967.PubMedCrossRefGoogle Scholar
  15. 15.
    Korf, T., and Venema, K., 1983, Amino acids in the substantia nigra of rats with striatal lesions produced by kainic acid, J. Neurochem., 40:1171–1173.PubMedCrossRefGoogle Scholar
  16. 16.
    Lindgren, S., and Anden, N.E., 1985, Effect of the normal nerve impulse flow in the synthesis and utilization of GABA in the rat substantia nigra, J. Neurol. Transmission, 61:21–34.CrossRefGoogle Scholar
  17. 17.
    Lombardini, J.B., 1976, Regional and subcellular studies on taurine in the rat central nervous system, in: “Taurine”, R.J. Huxtable, and A. Barbeau, eds., Raven Press, New York, pp. 311–326.Google Scholar
  18. 18.
    Lombardini, J.B., 1977, High affinity uptake systems for taurine in tissue slices and synaptosomal fractions prepared from various regions of the rat central nervous system. Correction of transport data by different experimental procedures, J. Neurochem., 29:305–312.PubMedCrossRefGoogle Scholar
  19. 19.
    Mandel, P., and Pasantes-Morales, H., 1978, Taurine in the nervous system, Rev. Neurosci., 3:157–193.Google Scholar
  20. 20.
    Martin, G.E., Benedesky, R.J., and Williams, M., 1981, Further evidence for selective antagonism of taurine by 6-aminomethyl-3-methyl-4H-l,2,4-benzothiadiazine-l,l-dioxide, Brain Res., 229:530–535.PubMedCrossRefGoogle Scholar
  21. 21.
    Meiners, B.A., Speth, R.C., Bresolin, N., Huxtable, R.J., and Yamamura, H.I., 1980, Sodium-dependent, high affinity taurine transport into rat brain synaptosomes, Federation Proc., 39:2695–2700.Google Scholar
  22. 22.
    Nicklas, W.J., Duvoisin, R.C., and Berl, S., 1979, Amino acids in rat neostriatum: alterations by kainic acid lesions, Brain Res., 167:107–117.PubMedCrossRefGoogle Scholar
  23. 23.
    Oja, S.S., and Kontro, P., 1978, Neurotransmitter actions of taurine in the central nervous system. in: “Taurine in Neurological Disorders”, A, Barbeau and R.J., Huxtable eds., Raven Press, New York, pp. 181–200.Google Scholar
  24. 24.
    Pin, J.P., Weiss, S., Sebben, M., Kemp, D.E., and Bockaert, J., 1986, Release of endogenous amino acids from striatal neurons in primary culture, J. Neurochem., 47:594–603.PubMedCrossRefGoogle Scholar
  25. 25.
    Placheta, P., Singer, E., Schonbeck, G., Heckl, K., and Karobath, M., 1979, Reduction of endogenous level, uptake and release of taurine after intrastriatal kainic acid injection, Neuropharmacology, 18:339–402.CrossRefGoogle Scholar
  26. 26.
    Pycock, C.J., and Smith, L.F.P., 1983, Interactions of dopamine and the release of [3H]-taurine and [3H]-glycine from the isolated retina of the rat, Br. J. Pharmacol., 78:395–404.PubMedCrossRefGoogle Scholar
  27. 27.
    Somogyi, P., Bolam, J.P., and Smith, A.D., 1981, Monosynaptic cortical input and local axon collaterals of identified striatonigral fleurons. A light and electron microscopic study using the Golgi-peroxidase transport-degeneration procedure, J. Comp. Neurol., 195:567–584.PubMedCrossRefGoogle Scholar
  28. 28.
    Somogyi, P., Hodgson, A.J., and Smith, A.D., 1979, An approach to tracing neuron networks in the cerebral cortex and basal ganglia. Combination of Golgi staining, retrograde degeneration of synaptic boutons in the same material, Neuroscience, 4:1805–1852.PubMedCrossRefGoogle Scholar
  29. 29.
    Somogyi, P., and Smith, A.D., 1979, Projection of neostriatal spiny neurons to the substantia nigra. Application of a combined Golgi-staining and horseradish peroxidase transport procedure at both light and electron microscopic levels, Brain Res., 178:3–15.PubMedCrossRefGoogle Scholar
  30. 30.
    Spears, R.M., and Martin, D.L., 1982, Resolution and brain regional distribution of cysteine sulphinate decarboxylase isoenzyme from hog brain, J. Neurochem., 38:985–991.PubMedCrossRefGoogle Scholar
  31. 31.
    Wu, T.Y., Bird, E.D., Chen, M.S., and Huang, W.M., 1979, Abnormalities of neurotransmitter enzymes in Huntington’s chorea, Neurochem. Res., 4:575–586.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • L. Della Corte
    • 1
    • 2
  • D. J. Clarke
    • 1
  • J. P. Bolam
    • 1
  • A. D. Smith
    • 1
  1. 1.University Department of PharmacologyOxfordUK
  2. 2.Dip.to di Farmacologia Preclinica e ClinicaUniversita degli Studi di FirenzeFirenzeItaly

Personalised recommendations